Last reviewed · How we verify
NCT07400718
Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
NA trial testing AllerTest-10 Multi-Head Skin Test Device in Allergy in 30 participants. Completed in 30 January 2026.
30 November 2025
Quick facts
| Lead sponsor | QHSLab, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | diagnostic |
| Enrollment | 30 |
| Start date | 12 November 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- AllerTest-10 Multi-Head Skin Test Device
- Skintestor OMNI Multi-Head Skin Test Device
- Multi-Test II Multi-Head Skin Test Device
- AllerTest-8 Multi-Head Skin Test Device
Conditions studied
- Allergy — all drugs for Allergy →
- Hypersensitivity, Immediate — all drugs for Hypersensitivity, Immediate →
- Ig-E Mediated Food — all drugs for Ig-E Mediated Food →
Sponsor
QHSLab, Inc.
Who can join
Adults 18 to 65, any sex, with Allergy or Hypersensitivity, Immediate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study, titled "Head-to-Head Comparison Study between Different FDA Registered Allergy Skin Test Applicators," aims to compare the reliability and clinical performance of three skin prick test (SPT) devices: Allertest™ Multiple Skin Test Applicator, Lincoln Multi-Test II, and Greer Skintestor OMNI Applicator. The primary objective is to evaluate the consistency and accuracy of these devices in allergy testing.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparative Clinical Performance of Multiple-Head Skin Prick Test Devices: A Prospective Evaluation of Pain, Sensitivity, Specificity, and Intradevice Variability.
Sanchez-Gonzalez M, Grogan T, Smollar M, Rizvi SAA. · · 2026 · PMID 41853430 · DOI 10.7759/cureus.103646
Verify or expand the search:
- PubMed search for NCT07400718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Allergy
Currently open trials in the same condition.
- NCT05997784 — Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing · active not recruiting
- NCT06390878 — Nationwide Research on the Rewilding of Kindergarten Yards · NA · recruiting
- NCT06248957 — SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION · recruiting
- NCT05449756 — A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life · recruiting
- NCT06192914 — EPAP, Interviewstudy · recruiting
Other QHSLab, Inc. trials
Trials by the same sponsor.
- NCT06603935 — Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR) · NA · enrolling by invitation
- NCT06623799 — Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07400718 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by QHSLab, Inc.
- Last refreshed: 12 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07400718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing